Replies to post #236 on Alaunos Therapeutics Inc (TCRT)

[gator16]

May 20
SEATTLE--(BUSINESS WIRE)-- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP - News), and Intrexon Corporation announced today that results from two preclinical studies examining the tightly controlled, intra-tumoral expression of a novel protein, interleukin-12 (IL-12), in melanoma, colon, lung, leukemia, breast and pancreatic cancer models in mice, were presented at the 2011 Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), held May 18 – 21 in Seattle, Washington.